2013年美国心力衰竭管理指南(心衰指南)课件 2_课件.pptVIP

2013 ACCF/AHA Guideline for the Management of Heart Failure;Citation;Clyde W. Yancy and Mariell Jessup ACCF/AHA Heart Failure Guideline Writing Committee Members Clyde W. Yancy, MD, MSc, FACC, FAHA, Chair?? Mariell Jessup, MD, FACC, FAHA, Vice Chair*?;Classification of Recommendations and Levels of Evidence;Stages, Phenotypes and Treatment of HF;Definition of Heart Failure;Classification of Heart Failure;Initial and Serial Evaluation of the HF Patient;History and Physical Examination;A thorough history and physical examination should be obtained/performed in patients presenting with HF to identify cardiac and noncardiac disorders or behaviors that might cause or accelerate the development or progression of HF. In patients with idiopathic DCM, a 3-generational family history should be obtained to aid in establishing the diagnosis of familial DCM. Volume status and vital signs should be assessed at each patient encounter. This includes serial assessment of weight, as well as estimates of jugular venous pressure and the presence of peripheral edema or orthopnea. ;Risk Scoring;Risk Scoring;Risk Scores to Predict Outcomes in HF;Diagnostic Tests;Diagnostic Tests;Diagnostic Tests (cont.);Biomarkers Ambulatory/Outpatient;Ambulatory/Outpatient;Ambulatory/Outpatient (cont.);Biomarkers Hospitalized/Acute;Hospitalized/Acute;Hospitalized/Acute (cont.);Recommendations for Biomarkers in HF;Causes for Elevated Natriuretic Peptide Levels;Noninvasive Cardiac Imaging;Noninvasive Cardiac Imaging;Noninvasive Cardiac Imaging (cont.);Noninvasive Cardiac Imaging (cont.);Recommendations for Noninvasive Imaging;Invasive Evaluation;Invasive Evaluation;Invasive Evaluation (cont.);Invasive Evaluation (cont.);Recommendations for Invasive Evaluation;Treatment of Stages A to D;Stage A;Stage A;Stage B;Stage B;Stage B (cont.);Stage B (cont.);Recommendations for Treatment of Stage B HF;Stage C;Nonpharmacological Interventions;Stage C: Nonpharmacological Interventions;Stage C: Nonpharmacolo